FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Ackerman

Research Profile

Disorders

Chemicals & Drugs

Physiology

Procedures

Living Beings

Concepts & Ideas

Retrospective Studies

Co-author Network

Publications

TOP 3
Daniel C Bartos; Rachel Bastiaenen; Elijah R Behr; Don E Burgess; Michael H Gollob; Pascale Guicheney; Tessa Homfray; Jonathan N Johnson; David J Tester; Michael J Ackerman; Jeffrey B Anderson; Brian P Delisle
A KCNQ1 Mutation Causes a High Penetrance for Familial Atrial Fibrillation.
Lia Crotti; Brian P Delisle; Fabio Facchinetti; Alfred L George; Alice Ghidoni; Roberto Insolia; Jennifer D Kunic; Peter J Schwartz; David J Tester; Daniel L Van Dyke; Ellyn J Velasco; Wendy M White; Myra J Wick; Melissa L Will; Jennifer J Bair; Daniel C Bartos; Alessandra Besana; Brian Brost; Irene Cetin; Michael J Ackerman
Long QT syndrome-associated mutations in intrauterine fetal death.
Kristina H Haugaa; Bruce W Morlan; Robert F Tarrell; J Martijn Bos; Pedro J Caraballo; Michael J Ackerman
Institution-wide QT alert system identifies patients with a high risk of mortality.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Ackerman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Daniel C Bartos; Rachel Bastiaenen; Elijah R Behr; Don E Burgess; Michael H Gollob; Pascale Guicheney; Tessa Homfray; Jonathan N Johnson; David J Tester; Michael J Ackerman; Jeffrey B Anderson; Brian P Delisle
A KCNQ1 Mutation Causes a High Penetrance for Familial Atrial Fibrillation.
Journal of cardiovascular electrophysiology 2013;24(5):562-9.
2013: Lia Crotti; Brian P Delisle; Fabio Facchinetti; Alfred L George; Alice Ghidoni; Roberto Insolia; Jennifer D Kunic; Peter J Schwartz; David J Tester; Daniel L Van Dyke; Ellyn J Velasco; Wendy M White; Myra J Wick; Melissa L Will; Jennifer J Bair; Daniel C Bartos; Alessandra Besana; Brian Brost; Irene Cetin; Michael J Ackerman
Long QT syndrome-associated mutations in intrauterine fetal death.
JAMA : the journal of the American Medical Association 2013;309(14):1473-82.
2013: Kristina H Haugaa; Bruce W Morlan; Robert F Tarrell; J Martijn Bos; Pedro J Caraballo; Michael J Ackerman
Institution-wide QT alert system identifies patients with a high risk of mortality.
Mayo Clinic proceedings. Mayo Clinic 2013;88(4):315-25.
2013: John R Giudicessi; Michael J Ackerman
Prevalence and Potential Genetic Determinants of Sensorineural Deafness in KCNQ1 Homozygosity and Compound Heterozygosity.
Circulation. Cardiovascular genetics 2013;6(2):193-200.
2013: Gregory A Nuttall; William C Oliver; Tricia D Renk; Laurie C Trudell; Ann M Malone; Mary E Shirk Marienau; Carrie A Michels; Michael J Ackerman
Does low-dose droperidol increase the risk of polymorphic ventricular tachycardia or death in the surgical patient?
Anesthesiology 2013;118(2):382-6.
2013: Salah E Altarabsheh; Harold M Burkhart; Joseph A Dearani; Salil V Deo; Benjamin W Eidem; Zhuo Li; Steve R Ommen; Hartzell V Schaff; Michael J Ackerman
Outcome of septal myectomy for obstructive hypertrophic cardiomyopathy in children and young adults.
The Annals of thoracic surgery 2013;95(2):663-9; discussion 669.
2013: Jonathan N Johnson; Michael J Ackerman
Return to play? Athletes with congenital long QT syndrome.
British journal of sports medicine 2013;47(1):28-33.
2013: John R Giudicessi; Michael J Ackerman
Determinants of incomplete penetrance and variable expressivity in heritable cardiac arrhythmia syndromes.
Translational research : the journal of laboratory and clinical medicine 2013;161(1):1-14.
2012: Sadguna Y Balijepalli; Chen L Chew; Sarah P Concannon; Brian P Delisle; Kassandra E Holzem; Michael J Ackerman; Ravi C Balijepalli; Evi Lim; David J Tester; Craig T January
Mechanism of loss of Kv11.1 K+ current in mutant T421M-Kv11.1-expressing rat ventricular myocytes: interaction of trafficking and gating.
Circulation 2012;126(24):2809-18.
2012: J Martijn Bos; Michael J Ackerman
Arrhythmias: Epinephrine test for sudden cardiac death--is it too early?
Nature reviews. Cardiology 2012;9(12):675-6.
2012: Taisuke Ishikawa; Michael J Ackerman; Takuro Arimura; Lia Crotti; Masayasu Hiraoka; Naomasa Makita; Cherisse A Marcou; Kazufumi Nakamura; Kiyoshi Nakazawa; Young Keun On; Jeong Euy Park; Harumizu Sakurada; Akinori Sato; Peter J Schwartz; David J Tester; Akinori Kimura
A novel disease gene for Brugada syndrome: sarcolemmal membrane-associated protein gene mutations impair intracellular trafficking of hNav1.5.
Circulation. Arrhythmia and electrophysiology 2012;5(6):1098-107.
2012: Morgan M Medlock; David J Tester; Melissa L Will; J Martijn Bos; Michael J Ackerman
Repeat long QT syndrome genetic testing of phenotype-positive cases: prevalence and etiology of detection misses.
Heart rhythm : the official journal of the Heart Rhythm Society 2012;9(12):1977-82.
2012: Don E Burgess; Kenneth S Campbell; Michael J Ackerman; Daniel C Bartos; Isabelle Denjoy; Véronique Fressart; Pascale Guicheney; Minoru Horie; Jonathan N Johnson; Arthur J Moss; Seiko Ohno; Allison R Reloj; David J Tester; Brian P Delisle
High-risk long QT syndrome mutations in the Kv7.1 (KCNQ1) pore disrupt the molecular basis for rapid K(+) permeation.
Biochemistry 2012;51(45):9076-85.
2012: Michelle S Parvatiyar; Michael J Ackerman; Cicero Figueiredo-Freitas; Andrew P Landstrom; James D Potter; Jose Renato Pinto
A mutation in TNNC1-encoded cardiac troponin C, TNNC1-A31S, predisposes to hypertrophic cardiomyopathy and ventricular fibrillation.
The Journal of biological chemistry 2012;287(38):31845-55.
2012: John R Giudicessi; Kyle D Traynor; Brian C Brost; Michael J Ackerman
Potential depot medroxyprogesterone acetate-triggered torsades de pointes in a case of congenital type 2 long QT syndrome.
Heart rhythm : the official journal of the Heart Rhythm Society 2012;9(7):1143-7.
2012: David J Tester; Melissa L Will; Carla M Haglund; Argelia Medeiros Domingo; Michael J Ackerman
Cardiac channel molecular autopsy: insights from 173 consecutive cases of autopsy-negative sudden unexplained death referred for postmortem genetic testing.
Mayo Clinic proceedings. Mayo Clinic 2012;87(6):524-39.
2012: Andrew P Landstrom; Michael J Ackerman
Beyond the cardiac myofilament: hypertrophic cardiomyopathy- associated mutations in genes that encode calcium-handling proteins.
Current molecular medicine 2012;12(5):507-18.
2012: John R Giudicessi; Chad J Kritzberger; Vladislav V Nesterenko; David J Tester; Dan Ye; Charles Antzelevitch; Michael J Ackerman
Novel mutations in the KCND3-encoded Kv4.3 K+ channel associated with autopsy-negative sudden unexplained death.
Human mutation 2012;33(6):989-97.
2012: J Martijn Bos; Imke Christiaans; William D Edwards; John Hawse; Joseph J Maleszewski; Nalini M Rajamannan; Thomas C Spelsberg; Malayannan Subramaniam; Arthur A M Wilde; Michael J Ackerman
TGFβ-inducible early gene-1 (TIEG1) mutations in hypertrophic cardiomyopathy.
Journal of cellular biochemistry 2012;113(6):1896-903.
2012: David J Tester; Michael J Ackerman
The molecular autopsy: should the evaluation continue after the funeral?
Pediatric cardiology 2012;33(3):461-70.
2012: Keith A Dufendach; Justin M Horner; Bryan C Cannon; Michael J Ackerman
Congenital type 1 long QT syndrome unmasked by a highly caffeinated energy drink.
Heart rhythm : the official journal of the Heart Rhythm Society 2012;9(2):285-8.
2012: David W Van Norstrand; Angeliki Asimaki; Elena Dolmatova; Heather S Duffy; Clio Rubinos; Jeffrey E Saffitz; Miduturu Srinivas; David J Tester; Michael J Ackerman
Connexin43 mutation causes heterogeneous gap junction loss and sudden infant death.
Circulation 2012;125(3):474-81.
2011: Justin M Horner; Melissa M Horner; Michael J Ackerman
The diagnostic utility of recovery phase QTc during treadmill exercise stress testing in the evaluation of long QT syndrome.
Heart rhythm : the official journal of the Heart Rhythm Society 2011;8(11):1698-704.
2011: David J Tester; Melissa L Will; Argelia Medeiros Domingo; Michael J Ackerman
Unexplained drownings and the cardiac channelopathies: a molecular autopsy series.
Mayo Clinic proceedings. Mayo Clinic 2011;86(10):941-7.
2011: Andrew P Landstrom; Michael J Ackerman
The Achilles' heel of cardiovascular genetic testing: distinguishing pathogenic mutations from background genetic noise.
Clinical pharmacology and therapeutics 2011;90(4):496-9.
2011: Jonathan N Johnson; Yung R Lau; Christopher Moir; Katy M Harris; Michael J Ackerman
Left cardiac sympathetic denervation in a pediatric patient with hypertrophic cardiomyopathy and recurrent ventricular fibrillation.
Heart rhythm : the official journal of the Heart Rhythm Society 2011;8(10):1591-4.
2011: Benjamin Kloesel; Bradly J Narr; Juraj Sprung; Michael J Ackerman; Toby N Weingarten
Anesthetic management of patients with Brugada syndrome: a case series and literature review.
Canadian journal of anaesthesia = Journal canadien d'anesthésie 2011;58(9):824-36.
2011: Mira A Coleman; Sabrina D Phillips; Joseph J Souza; J Martijn Bos; Michael J Ackerman
Left ventricular noncompaction syndrome masquerading or misdiagnosed as congenital long QT syndrome: remember QT prolongation does not equal long QT syndrome.
Congenital heart disease 2011;6(5):492-8.
2011: Daniel A Mauriello; Jonathan N Johnson; Michael J Ackerman
Holter monitoring in the evaluation of congenital long QT syndrome.
Pacing and clinical electrophysiology : PACE 2011;34(9):1100-4.
2011: Iacopo Olivotto; Roberto Sciagrà; Aurelio Sgalambro; Barbara Sotgia; Francesca Torricelli; Michael J Ackerman; J Martijn Bos; Paolo G Camici; Francesca Girolami; Camilla Grifoni; Stefano Nistri; franco cecchi
Microvascular function is selectively impaired in patients with hypertrophic cardiomyopathy and sarcomere myofilament gene mutations.
Journal of the American College of Cardiology 2011;58(8):839-48.
2011: Michael J Ackerman; Charles Berul; Ramon Brugada; Hugh Calkins; A John Camm; Patrick T Ellinor; Michael Gollob; Robert Hamilton; Ray E Hershberger; Daniel P Judge; Hervè Le Marec; William J McKenna; Silvia G Priori; Eric Schulze-Bahr; Chris Semsarian; Jeffrey A Towbin; Hugh Watkins; Arthur Wilde; Stephan Willems; Christian Wolpert; Douglas P Zipes
HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2011;13(8):1077-109.
2011: Michael J Ackerman; Charles Berul; Ramon Brugada; Hugh Calkins; A John Camm; Patrick T Ellinor; Michael Gollob; Robert Hamilton; Ray E Hershberger; Daniel P Judge; Hervè Le Marec; William J McKenna; Silvia G Priori; Eric Schulze-Bahr; Chris Semsarian; Jeffrey A Towbin; Hugh Watkins; Arthur Wilde; Stephan Willems; Christian Wolpert; Douglas P Zipes
HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA).
Heart rhythm : the official journal of the Heart Rhythm Society 2011;8(8):1308-39.
2011: Jonathan N Johnson; Michelle L Marquardt; Guy S Reeder; Michael J Ackerman; Samuel J Asirvatham; Allison K Cabalka; Frank Cetta; Donald J Hagler
Electrocardiographic changes and arrhythmias following percutaneous atrial septal defect and patent foramen ovale device closure.
Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions 2011;78(2):254-61.
2011: Brian D Moseley; Katherine Nickels; Elaine Wirrell; Michael J Ackerman; Jonathan N Johnson; Jeffrey Britton
Electrocardiographic and oximetric changes during partial complex and generalized seizures.
Epilepsy research 2011;95(3):237-45.
2011: John R Giudicessi; Alessandra Mugione; Vladislav V Nesterenko; Peter J Schwartz; David J Tester; Dan Ye; Richard M Albertson; Charles Antzelevitch; Lia Crotti; Michael J Ackerman
Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome.
Heart rhythm : the official journal of the Heart Rhythm Society 2011;8(7):1024-32.
2011: Jamie D Kapplinger; Andrew P Landstrom; Salisbury Benjamin; Thomas E Callis; Guido D Pollevick; David J Tester; Moniek G P J Cox; Zahurul A Bhuiyan; Hennie Bikker; Ans C P Wiesfeld; Richard N W Hauer; J Peter van Tintelen; Jan D H Jongbloed; Hugh Calkins; Daniel P Judge; Arthur A M Wilde; Michael J Ackerman
Distinguishing arrhythmogenic right ventricular cardiomyopathy/dysplasia-associated mutations from background genetic noise.
Journal of the American College of Cardiology 2011;57(23):2317-27.
2011: Jianding Cheng; David J Tester; Bi-Hua Tan; Carmen R Valdivia; Stacie Kroboth; Bin Ye; Craig T January; Michael J Ackerman; Jonathan C Makielski
The common African American polymorphism SCN5A-S1103Y interacts with mutation SCN5A-R680H to increase late Na current.
Physiological genomics 2011;43(9):461-6.
2011: Jonathan N Johnson; Camilla Grifoni; J Martijn Bos; Maha Saber-Ayad; Steve R Ommen; Stefano Nistri; franco cecchi; Iacopo Olivotto; Michael J Ackerman
Prevalence and clinical correlates of QT prolongation in patients with hypertrophic cardiomyopathy.
European heart journal 2011;32(9):1114-20.
2011: Ralph J van Oort; Alejandro Garbino; Wei Wang; Sayali S Dixit; Andrew P Landstrom; Namit Gaur; Angela C De Almeida; Darlene G Skapura; Yoram Rudy; Alan R Burns; Michael J Ackerman; Xander H T Wehrens
Disrupted junctional membrane complexes and hyperactive ryanodine receptors after acute junctophilin knockdown in mice.
Circulation 2011;123(9):979-88.
2011: Andrew P Landstrom; Cherisse A Kellen; Sayali S Dixit; Ralph J van Oort; Alejandro Garbino; Noah Weisleder; Jianjie Ma; Xander H T Wehrens; Michael J Ackerman
Junctophilin-2 expression silencing causes cardiocyte hypertrophy and abnormal intracellular calcium-handling.
Circulation. Heart failure 2011;4(2):214-23.
2011: Andrew P Landstrom; Babatunde A Adekola; J Martijn Bos; Steve R Ommen; Michael J Ackerman
PLN-encoded phospholamban mutation in a large cohort of hypertrophic cardiomyopathy cases: summary of the literature and implications for genetic testing.
American heart journal 2011;161(1):165-71.
2011: Daniel C Bartos; Sabine Duchatelet; Don E Burgess; Didier Klug; Isabelle Denjoy; Rachel Peat; Jean-Marc Lupoglazoff; Véronique Fressart; Myriam Berthet; Michael J Ackerman; Craig T January; Pascale Guicheney; Brian P Delisle
R231C mutation in KCNQ1 causes long QT syndrome type 1 and familial atrial fibrillation.
Heart rhythm : the official journal of the Heart Rhythm Society 2011;8(1):48-55.
2010: Jonathan N Johnson; Michael J Ackerman
The prevalence and diagnostic/prognostic utility of sinus arrhythmia in the evaluation of congenital long QT syndrome.
Heart rhythm : the official journal of the Heart Rhythm Society 2010;7(12):1785-9.
2010: J Martijn Bos; Barry J Maron; Michael J Ackerman; Tammy S Haas; Paul Sorajja; Rick A Nishimura; Bernard J Gersh; Steve R Ommen
Role of family history of sudden death in risk stratification and prevention of sudden death with implantable defibrillators in hypertrophic cardiomyopathy.
The American journal of cardiology 2010;106(10):1481-6.
2010: Justin M Horner; Masayoshi Kinoshita; Tracy L Webster; Carla M Haglund; Paul A Friedman; Michael J Ackerman
Implantable cardioverter defibrillator therapy for congenital long QT syndrome: a single-center experience.
Heart rhythm : the official journal of the Heart Rhythm Society 2010;7(11):1616-22.
2010: David J Tester; Amber J Benton; Laura Train; Barbara Deal; Linnea M Baudhuin; Michael J Ackerman
Prevalence and spectrum of large deletions or duplications in the major long QT syndrome-susceptibility genes and implications for long QT syndrome genetic testing.
The American journal of cardiology 2010;106(8):1124-8.
2010: Argelia Medeiros Domingo; Bi-Hua Tan; Lia Crotti; David J Tester; Lee Eckhardt; Alessandra Cuoretti; Stacie L Kroboth; chunhua song; Qing Zhou; Doug Kopp; Peter J Schwartz; Jonathan C Makielski; Michael J Ackerman
Gain-of-function mutation S422L in the KCNJ8-encoded cardiac K(ATP) channel Kir6.1 as a pathogenic substrate for J-wave syndromes.
Heart rhythm : the official journal of the Heart Rhythm Society 2010;7(10):1466-71.
2010: Emily Gertsch; Salman Kirmani; Michael J Ackerman; Dusica Babovic-Vuksanovic
Transient QT interval prolongation in an infant with Simpson-Golabi-Behmel syndrome.
American journal of medical genetics. Part A 2010;152A(9):2379-82.
2010: Paola Lanfranchi; Michael J Ackerman; Tomas Kara; Abu S M Shamsuzzaman; Robert Wolk; Pavel Jurak; Raouf Amin; Virend K Somers
Gene-specific paradoxical QT responses during rapid eye movement sleep in women with congenital long QT syndrome.
Heart rhythm : the official journal of the Heart Rhythm Society 2010;7(8):1067-74.
2010: David J Tester; Carmen R Valdivia; Carole Harris-Kerr; Marielle Alders; Salisbury Benjamin; Arthur A M Wilde; Jonathan C Makielski; Michael J Ackerman
Epidemiologic, molecular, and functional evidence suggest A572D-SCN5A should not be considered an independent LQT3-susceptibility mutation.
Heart rhythm : the official journal of the Heart Rhythm Society 2010;7(7):912-9.
2010: Jonathan N Johnson; David J Tester; Nancy E Bass; Michael J Ackerman
Cardiac channel molecular autopsy for sudden unexpected death in epilepsy.
Journal of child neurology 2010;25(7):916-21.
2010: Eric C Lin; Katherine M Holzem; Blake D Anson; Brooke M Moungey; Sadguna Y Balijepalli; David J Tester; Michael J Ackerman; Brian P Delisle; Ravi C Balijepalli; Craig T January
Properties of WT and mutant hERG K(+) channels expressed in neonatal mouse cardiomyocytes.
American journal of physiology. Heart and circulatory physiology 2010;298(6):H1842-9.
2010: Bi-Hua Tan; Kavitha N Pundi; David W Van Norstrand; Carmen R Valdivia; David J Tester; Argelia Medeiros Domingo; Jonathan C Makielski; Michael J Ackerman
Sudden infant death syndrome-associated mutations in the sodium channel beta subunits.
Heart rhythm : the official journal of the Heart Rhythm Society 2010;7(6):771-8.
2010: Carmen R Valdivia; Argelia Medeiros Domingo; Bin Ye; Win-Kuang Shen; Timothy J Algiers; Michael J Ackerman; Jonathan C Makielski
Loss-of-function mutation of the SCN3B-encoded sodium channel {beta}3 subunit associated with a case of idiopathic ventricular fibrillation.
Cardiovascular research 2010;86(3):392-400.
2010: Christine A Kenyon; Randall P Flick; Christopher Moir; Michael J Ackerman; Christina M Pabelick
Anesthesia for videoscopic left cardiac sympathetic denervation in children with congenital long QT syndrome and catecholaminergic polymorphic ventricular tachycardia--a case series.
Paediatric anaesthesia 2010;20(5):465-70.
2010: J Martijn Bos; Michael J Ackerman
Z-disc genes in hypertrophic cardiomyopathy: stretching the cardiomyopathies?
Journal of the American College of Cardiology 2010;55(11):1136-8.
2010: David W Van Norstrand; Michael J Ackerman
Genomic risk factors in sudden infant death syndrome.
Genome medicine 2010;2(11):86.
2010: Jamie D Kapplinger; David J Tester; Marielle Alders; Begoña Benito; Myriam Berthet; Josep Brugada; Pedro Brugada; Véronique Fressart; Alejandra Guerchicoff; Carole Harris-Kerr; Shiro Kamakura; Florence Kyndt; Tamara T Koopmann; Yoshihiro Miyamoto; Ryan Pfeiffer; Guido D Pollevick; Vincent Probst; Sven Zumhagen; Matteo Vatta; Jeffrey A Towbin; Wataru Shimizu; Eric Schulze-Bahr; Charles Antzelevitch; Salisbury Benjamin; Pascale Guicheney; Arthur A M Wilde; Ramon Brugada; Jean-Jacques Schott; Michael J Ackerman
An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing.
Heart rhythm : the official journal of the Heart Rhythm Society 2010;7(1):33-46.
2010: Ronen Rubinshtein; James F Glockner; Steve R Ommen; Philip A Araoz; Michael J Ackerman; Paul Sorajja; J Martijn Bos; A Jamil Tajik; uma valeti; Rick A Nishimura; Bernard J Gersh
Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
Circulation. Heart failure 2010;3(1):51-8.
2009: Jianding Cheng; David W Van Norstrand; Argelia Medeiros Domingo; Carmen R Valdivia; Bi-hua Tan; Bin Ye; Stacie Kroboth; Matteo Vatta; David J Tester; Craig T January; Jonathan C Makielski; Michael J Ackerman
Alpha1-syntrophin mutations identified in sudden infant death syndrome cause an increase in late cardiac sodium current.
Circulation. Arrhythmia and electrophysiology 2009;2(6):667-76.
2009: Andrew P Landstrom; Michael J Ackerman
GWAS or Gee Whiz, PSAS or Pshaw: elucidating the biologic and clinical significance of genetic variation in cardiovascular disease.
Heart rhythm : the official journal of the Heart Rhythm Society 2009;6(12):1751-3.
2009: Shaji Chandran Menon; Benjamin W Eidem; Joseph A Dearani; Steve R Ommen; Michael J Ackerman; Dylan Miller
Diastolic dysfunction and its histopathological correlation in obstructive hypertrophic cardiomyopathy in children and adolescents.
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2009;22(12):1327-34.
2009: Argelia Medeiros Domingo; Zahurul A Bhuiyan; David J Tester; Nynke Hofman; Hennie Bikker; J Peter van Tintelen; marcel mannens; Arthur A M Wilde; Michael J Ackerman
The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis.
Journal of the American College of Cardiology 2009;54(22):2065-74.
2009: Suraj Kapa; David J Tester; Benjamin A Salisbury; Carole Harris-Kerr; Manish S Pungliya; Marielle Alders; Arthur A M Wilde; Michael J Ackerman
Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants.
Circulation 2009;120(18):1752-60.
2009: Christopher J McLeod; J Martijn Bos; Jeanne L Theis; William D Edwards; Bernard J Gersh; Steve R Ommen; Michael J Ackerman
Histologic characterization of hypertrophic cardiomyopathy with and without myofilament mutations.
American heart journal 2009;158(5):799-805.
2009: Amanda L Vega; David J Tester; Michael J Ackerman; Jonathan C Makielski
Protein kinase A-dependent biophysical phenotype for V227F-KCNJ2 mutation in catecholaminergic polymorphic ventricular tachycardia.
Circulation. Arrhythmia and electrophysiology 2009;2(5):540-7.
2009: Carmen R Valdivia; Kazuo Ueda; Michael J Ackerman; Jonathan C Makielski
GPD1L links redox state to cardiac excitability by PKC-dependent phosphorylation of the sodium channel SCN5A.
American journal of physiology. Heart and circulatory physiology 2009;297(4):H1446-52.
2009: J N Johnson; Michael J Ackerman
QTc: how long is too long?
British journal of sports medicine 2009;43(9):657-62.
2009: Jamie D Kapplinger; David J Tester; Salisbury Benjamin; Janet L Carr; Carole Harris-Kerr; Guido D Pollevick; Arthur A M Wilde; Michael J Ackerman
Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test.
Heart rhythm : the official journal of the Heart Rhythm Society 2009;6(9):1297-303.
2009: Lori A Blauwet; Michael J Ackerman; William D Edwards; Darren L Riehle; Steve R Ommen
Myocardial fibrosis in patients with symptomatic obstructive hypertrophic cardiomyopathy: correlation with echocardiographic measurements, sarcomeric genotypes, and pro-left ventricular hypertrophy polymorphisms involving the renin-angiotensin-aldosterone system.
Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology 2009;18(5):262-8.
2009: Argelia Medeiros Domingo; Bi-Hua Tan; Pedro Iturralde Torres; David J Tester; Teresa Tusié-Luna; Jonathan C Makielski; Michael J Ackerman
Unique mixed phenotype and unexpected functional effect revealed by novel compound heterozygosity mutations involving SCN5A.
Heart rhythm : the official journal of the Heart Rhythm Society 2009;6(8):1170-5.
2009: T Ben Morrison; Michael J Ackerman; Robert F Rea
Subacute perforation of the St. Jude Riata implantable cardioverter-defibrillator lead: a report of two pediatric cases.
Pediatric cardiology 2009;30(6):834-6.
2009: Takuro Arimura; J Martijn Bos; Akinori Sato; Toru Kubo; Hiroshi Okamoto; Hirofumi Nishi; Haruhito Harada; Yoshinori Koga; Mousumi Moulik; Yoshinori L Doi; Jeffrey A Towbin; Michael J Ackerman; Akinori Kimura
Cardiac ankyrin repeat protein gene (ANKRD1) mutations in hypertrophic cardiomyopathy.
Journal of the American College of Cardiology 2009;54(4):334-42.
2009: Christopher J McLeod; Michael J Ackerman; Rick A Nishimura; A Jamil Tajik; Bernard J Gersh; Steve R Ommen
Outcome of patients with hypertrophic cardiomyopathy and a normal electrocardiogram.
Journal of the American College of Cardiology 2009;54(3):229-33.
2009: J Martijn Bos; Jeffrey A Towbin; Michael J Ackerman
Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy.
Journal of the American College of Cardiology 2009;54(3):201-11.
2009: Jeanne L Theis; J Martijn Bos; Jason D Theis; Dylan V Miller; Joseph A Dearani; Hartzell V Schaff; Bernard J Gersh; Steve R Ommen; Richard L Moss; Michael J Ackerman
Expression patterns of cardiac myofilament proteins: genomic and protein analysis of surgical myectomy tissue from patients with obstructive hypertrophic cardiomyopathy.
Circulation. Heart failure 2009;2(4):325-33.
2009: Michael J Ackerman
State of postmortem genetic testing known as the cardiac channel molecular autopsy in the forensic evaluation of unexplained sudden cardiac death in the young.
Pacing and clinical electrophysiology : PACE 2009;32 Suppl 2():S86-9.
2009: Christopher A Collura; Jonathan N Johnson; Christopher Moir; Michael J Ackerman
Left cardiac sympathetic denervation for the treatment of long QT syndrome and catecholaminergic polymorphic ventricular tachycardia using video-assisted thoracic surgery.
Heart rhythm : the official journal of the Heart Rhythm Society 2009;6(6):752-9.
2009: Alejandro Garbino; Ralph J van Oort; Sayali S Dixit; Andrew P Landstrom; Michael J Ackerman; Xander H T Wehrens
Molecular evolution of the junctophilin gene family.
Physiological genomics 2009;37(3):175-86.
2009: David W Van Norstrand; Michael J Ackerman
Sudden infant death syndrome: do ion channels play a role?
Heart rhythm : the official journal of the Heart Rhythm Society 2009;6(2):272-8.
2009: David J Tester; Michael J Ackerman
Cardiomyopathic and channelopathic causes of sudden unexplained death in infants and children.
Annual review of medicine 2009;60():69-84.
2008: Shaji Chandran Menon; Michael J Ackerman; Frank Cetta; Patrick W O'Leary; Benjamin W Eidem
Significance of left atrial volume in patients < 20 years of age with hypertrophic cardiomyopathy.
The American journal of cardiology 2008;102(10):1390-3.
2008: Martin S Maron; John J Finley; J Martijn Bos; Thomas H Hauser; Warren J Manning; Tammy S Haas; John R Lesser; James E Udelson; Michael J Ackerman; Barry J Maron
Prevalence, clinical significance, and natural history of left ventricular apical aneurysms in hypertrophic cardiomyopathy.
Circulation 2008;118(15):1541-9.
2008: Harinath Sale; Jinling Wang; Thomas J O'Hara; David J Tester; Pallavi Phartiyal; Jia-Qiang He; Yoram Rudy; Michael J Ackerman; Gail A Robertson
Physiological properties of hERG 1a/1b heteromeric currents and a hERG 1b-specific mutation associated with Long-QT syndrome.
Circulation research 2008;103(7):e81-95.
2008: David J Tester; Michael J Ackerman
Novel gene and mutation discovery in congenital long QT syndrome: let's keep looking where the street lamp standeth.
Heart rhythm : the official journal of the Heart Rhythm Society 2008;5(9):1282-4.
2008: Andrew P Landstrom; Michelle S Parvatiyar; Jose R Pinto; Michelle L Marquardt; J Martijn Bos; David J Tester; Steve R Ommen; James D Potter; Michael J Ackerman
Molecular and functional characterization of novel hypertrophic cardiomyopathy susceptibility mutations in TNNC1-encoded troponin C.
Journal of molecular and cellular cardiology 2008;45(2):281-8.
2008: Kazuo Ueda; Carmen R Valdivia; Argelia Medeiros Domingo; David J Tester; Matteo Vatta; Gianrico Farrugia; Michael J Ackerman; Jonathan C Makielski
Syntrophin mutation associated with long QT syndrome through activation of the nNOS-SCN5A macromolecular complex.
Proceedings of the National Academy of Sciences of the United States of America 2008;105(27):9355-60.
2008: Iacopo Olivotto; Francesca Girolami; Michael J Ackerman; Stefano Nistri; J Martijn Bos; Elisabetta Zachara; Steve R Ommen; Jeanne L Theis; Rachael A Vaubel; Federica Re; Corinna Armentano; Corrado Poggesi; Francesca Torricelli; franco cecchi
Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy.
Mayo Clinic proceedings. Mayo Clinic 2008;83(6):630-8.
2008: J Martijn Bos; Jeanne L Theis; A Jamil Tajik; Bernard J Gersh; Steve R Ommen; Michael J Ackerman
Relationship between sex, shape, and substrate in hypertrophic cardiomyopathy.
American heart journal 2008;155(6):1128-34.
2008: Shaji Chandran Menon; Michael J Ackerman; Steve R Ommen; Allison K Cabalka; Donald J Hagler; Patrick W O'Leary; Joseph A Dearani; Frank Cetta; Benjamin W Eidem
Impact of septal myectomy on left atrial volume and left ventricular diastolic filling patterns: an echocardiographic study of young patients with obstructive hypertrophic cardiomyopathy.
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2008;21(6):684-8.
2008: David W Van Norstrand; David J Tester; Michael J Ackerman
Overrepresentation of the proarrhythmic, sudden death predisposing sodium channel polymorphism S1103Y in a population-based cohort of African-American sudden infant death syndrome.
Heart rhythm : the official journal of the Heart Rhythm Society 2008;5(5):712-5.
2008: Jonathan N Johnson; David J Tester; James Perry; Salisbury Benjamin; Carol R Reed; Michael J Ackerman
Prevalence of early-onset atrial fibrillation in congenital long QT syndrome.
Heart rhythm : the official journal of the Heart Rhythm Society 2008;5(5):704-9.
2008: Himeshkumar Vyas; Patrick W O'Leary; Michael G Earing; Frank Cetta; Michael J Ackerman
Mechanical dysfunction in extreme QT prolongation.
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2008;21(5):511.e15-7.
2008: Malek El Yaman; James Perry; Jonathan C Makielski; Michael J Ackerman
Suppression of atrial fibrillation with mexiletine pharmacotherapy in a young woman with type 1 long QT syndrome.
Heart rhythm : the official journal of the Heart Rhythm Society 2008;5(3):472-4.
2007: Michael J Ackerman; Andrew P Landstrom
Detection of subclinical fabry disease in patients presenting with hypertrophic cardiomyopathy.
Journal of the American College of Cardiology 2007;50(25):2404-5.
2007: Bi-Hua Tan; Pedro Iturralde Torres; Argelia Medeiros Domingo; Santiago Nava; David J Tester; Carmen R Valdivia; Teresa Tusié-Luna; Michael J Ackerman; Jonathan C Makielski
A novel C-terminal truncation SCN5A mutation from a patient with sick sinus syndrome, conduction disorder and ventricular tachycardia.
Cardiovascular research 2007;76(3):409-17.
2007: David W Van Norstrand; Carmen R Valdivia; David J Tester; Kazuo Ueda; Barry London; Jonathan C Makielski; Michael J Ackerman
Molecular and functional characterization of novel glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) mutations in sudden infant death syndrome.
Circulation 2007;116(20):2253-9.
2007: Gregory A Nuttall; Karen M Eckerman; Kelly A Jacob; Erin M Pawlaski; Susan K Wigersma; Mary E Shirk Marienau; William C Oliver; Bradly J Narr; Michael J Ackerman
Does low-dose droperidol administration increase the risk of drug-induced QT prolongation and torsade de pointes in the general surgical population?
Anesthesiology 2007;107(4):531-6.
2007: Josepha Binder; Steve R Ommen; Horng H Chen; Michael J Ackerman; A Jamil Tajik; Allan S Jaffe
Usefulness of brain natriuretic peptide levels in the clinical evaluation of patients with hypertrophic cardiomyopathy.
The American journal of cardiology 2007;100(4):712-4.
2007: Komandoor Srivathsan; Apoor S Gami; Michael J Ackerman; Samuel J Asirvatham
Treatment of ventricular fibrillation in a patient with prior diagnosis of long QT syndrome: importance of precise electrophysiologic diagnosis to successfully ablate the trigger.
Heart rhythm : the official journal of the Heart Rhythm Society 2007;4(8):1090-3.
2007: Bhaswati Pandit; Anna Sarkozy; Len A Pennacchio; Claudio Carta; Kimihiko Oishi; Simone Martinelli; Edgar A Pogna; Wendy Schackwitz; Anna Ustaszewska; Andrew P Landstrom; J Martijn Bos; Steve R Ommen; Giorgia Esposito; Francesca Lepri; Faul Christian; Peter Mundel; Juan Pedro López-Siguero; Romano Tenconi; Angelo Selicorni; cesare rossi; Laura Mazzanti; Isabella Torrente; Bruno Marino; Maria Cristina Digilio; Giuseppe Zampino; Michael J Ackerman; Bruno Dallapiccola; Marco Tartaglia; Bruce D Gelb
Gain-of-function RAF1 mutations cause Noonan and LEOPARD syndromes with hypertrophic cardiomyopathy.
Nature genetics 2007;39(8):1007-12.
2007: Argelia Medeiros Domingo; Toshihiko Kaku; David J Tester; Pedro Iturralde Torres; Ajit Itty; Bin Ye; Carmen R Valdivia; Kazuo Ueda; Samuel Canizales-Quinteros; María Teresa Tusié-Luna; Jonathan C Makielski; Michael J Ackerman
SCN4B-encoded sodium channel beta4 subunit in congenital long-QT syndrome.
Circulation 2007;116(2):134-42.
2007: Argelia Medeiros Domingo; Pedro Iturralde Torres; Michael J Ackerman
[Clinical and genetic characteristics of long QT syndrome].
Revista española de cardiología 2007;60(7):739-52.
2007: Andrew P Landstrom; Noah Weisleder; Karin B Batalden; J Martijn Bos; David J Tester; Steve R Ommen; Xander H T Wehrens; William C Claycomb; Jae-Kyun Ko; Moonsun Hwang; Zui Pan; Jianjie Ma; Michael J Ackerman
Mutations in JPH2-encoded junctophilin-2 associated with hypertrophic cardiomyopathy in humans.
Journal of molecular and cellular cardiology 2007;42(6):1026-35.
2007: Nathaniel W Taggart; Carla M Haglund; David J Tester; Michael J Ackerman
Diagnostic miscues in congenital long-QT syndrome.
Circulation 2007;115(20):2613-20.
2007: J Martijn Bos; Steve R Ommen; Michael J Ackerman
Genetics of hypertrophic cardiomyopathy: one, two, or more diseases?
Current opinion in cardiology 2007;22(3):193-9.
2007: Lee L Eckhardt; Amanda L Farley; Esther Rodriguez; Karen Ruwaldt; Daniel Hammill; David J Tester; Michael J Ackerman; Jonathan C Makielski
KCNJ2 mutations in arrhythmia patients referred for LQT testing: a mutation T305A with novel effect on rectification properties.
Heart rhythm : the official journal of the Heart Rhythm Society 2007;4(3):323-9.
2007: Lisa B Cronk; Bin Ye; Toshihiko Kaku; David J Tester; Matteo Vatta; Jonathan C Makielski; Michael J Ackerman
Novel mechanism for sudden infant death syndrome: persistent late sodium current secondary to mutations in caveolin-3.
Heart rhythm : the official journal of the Heart Rhythm Society 2007;4(2):161-6.
2007: David J Tester; Michael J Ackerman
Postmortem long QT syndrome genetic testing for sudden unexplained death in the young.
Journal of the American College of Cardiology 2007;49(2):240-6.
2006: Jeanne L Theis; J Martijn Bos; Virginia B Bartleson; Melissa L Will; Josepha Binder; Matteo Vatta; Jeffrey A Towbin; Bernard J Gersh; Steve R Ommen; Michael J Ackerman
Echocardiographic-determined septal morphology in Z-disc hypertrophic cardiomyopathy.
Biochemical and biophysical research communications 2006;351(4):896-902.
2006: Himeshkumar Vyas; Katya Johnson; Robert Houlihan; Brent A Bauer; Michael J Ackerman
Acquired long QT syndrome secondary to cesium chloride supplement.
Journal of alternative and complementary medicine (New York, N.Y.) 2006;12(10):1011-4.
2006: Matteo Vatta; Michael J Ackerman; Bin Ye; Jonathan C Makielski; Enoh E Ughanze; Erica W Taylor; David J Tester; Ravi C Balijepalli; Jason D Foell; Zhaohui Li; Timothy J Kamp; Jeffrey A Towbin
Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome.
Circulation 2006;114(20):2104-12.
2006: Vlad C Vasile; William D Edwards; Steve R Ommen; Michael J Ackerman
Obstructive hypertrophic cardiomyopathy is associated with reduced expression of vinculin in the intercalated disc.
Biochemical and biophysical research communications 2006;349(2):709-15.
2006: Himeshkumar Vyas; Michael J Ackerman
Epinephrine QT stress testing in congenital long QT syndrome.
Journal of electrocardiology 2006;39(4 Suppl):S107-13.
2006: Vlad C Vasile; Steve R Ommen; William D Edwards; Michael J Ackerman
A missense mutation in a ubiquitously expressed protein, vinculin, confers susceptibility to hypertrophic cardiomyopathy.
Biochemical and biophysical research communications 2006;345(3):998-1003.
2006: David J Tester; Lisa B Cronk; Janet L Carr; Vincent Schulz; Salisbury Benjamin; Richard Judson; Michael J Ackerman
Allelic dropout in long QT syndrome genetic testing: a possible mechanism underlying false-negative results.
Heart rhythm : the official journal of the Heart Rhythm Society 2006;3(7):815-21.
2006: David J Tester; Puneeta Arya; Melissa L Will; Carla M Haglund; Amanda L Farley; Jonathan C Makielski; Michael J Ackerman
Genotypic heterogeneity and phenotypic mimicry among unrelated patients referred for catecholaminergic polymorphic ventricular tachycardia genetic testing.
Heart rhythm : the official journal of the Heart Rhythm Society 2006;3(7):800-5.
2006: Paul Sorajja; Rick A Nishimura; Steve R Ommen; Michael J Ackerman; A Jamil Tajik; Bernard J Gersh
Use of echocardiography in patients with hypertrophic cardiomyopathy: clinical implications of massive hypertrophy.
Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography 2006;19(6):788-95.
2006: J Martijn Bos; Rainer N Poley; Melissa Ny; David J Tester; Xiaolei Xu; Matteo Vatta; Jeffrey A Towbin; Bernard J Gersh; Steve R Ommen; Michael J Ackerman
Genotype-phenotype relationships involving hypertrophic cardiomyopathy-associated mutations in titin, muscle LIM protein, and telethonin.
Molecular genetics and metabolism 2006;88(1):78-85.
2006: Josepha Binder; Steve R Ommen; Bernard J Gersh; Sara L Van Driest; A Jamil Tajik; Rick A Nishimura; Michael J Ackerman
Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations.
Mayo Clinic proceedings. Mayo Clinic 2006;81(4):459-67.
2006: Himeshkumar Vyas; Joseph Hejlik; Michael J Ackerman
Epinephrine QT stress testing in the evaluation of congenital long-QT syndrome: diagnostic accuracy of the paradoxical QT response.
Circulation 2006;113(11):1385-92.
2006: David J Tester; Melissa L Will; Carla M Haglund; Michael J Ackerman
Effect of clinical phenotype on yield of long QT syndrome genetic testing.
Journal of the American College of Cardiology 2006;47(4):764-8.
2006: Vlad C Vasile; Melissa L Will; Steve R Ommen; William D Edwards; Timothy M Olson; Michael J Ackerman
Identification of a metavinculin missense mutation, R975W, associated with both hypertrophic and dilated cardiomyopathy.
Molecular genetics and metabolism 2006;87(2):169-74.
2006: Corey L Anderson; Brian P Delisle; Blake D Anson; Jennifer A Kilby; Melissa L Will; David J Tester; Qiuming Gong; Zhengfeng Zhou; Michael J Ackerman; Craig T January
Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism.
Circulation 2006;113(3):365-73.
2006: David J Tester; Melissa L Will; Michael J Ackerman
Mutation detection in congenital long QT syndrome: cardiac channel gene screen using PCR, dHPLC, and direct DNA sequencing.
Methods in molecular medicine 2006;128():181-207.
2006: Richard Judson; Salisbury Benjamin; Carol R Reed; Michael J Ackerman
Pharmacogenetic issues in thorough QT trials.
Molecular diagnosis & therapy 2006;10(3):153-62.
2005: Michael J Ackerman; Sara L Van Driest; Martijn Bos
Are longitudinal, natural history studies the next step in genotype-phenotype translational genomics in hypertrophic cardiomyopathy?
Journal of the American College of Cardiology 2005;46(9):1744-6.
2005: Patrick T Fitzgerald; Michael J Ackerman
Drug-induced torsades de pointes: the evolving role of pharmacogenetics.
Heart rhythm : the official journal of the Heart Rhythm Society 2005;2(2 Suppl):S30-7.
2005: Jonathan Sherman; David J Tester; Michael J Ackerman
Targeted mutational analysis of ankyrin-B in 541 consecutive, unrelated patients referred for long QT syndrome genetic testing and 200 healthy subjects.
Heart rhythm : the official journal of the Heart Rhythm Society 2005;2(11):1218-23.
2005: Meghan J Perkins; Sara L Van Driest; Erik G Ellsworth; Melissa L Will; Bernard J Gersh; Steve R Ommen; Michael J Ackerman
Gene-specific modifying effects of pro-LVH polymorphisms involving the renin-angiotensin-aldosterone system among 389 unrelated patients with hypertrophic cardiomyopathy.
European heart journal 2005;26(22):2457-62.
2005: David J Tester; Laura J Kopplin; Melissa L Will; Michael J Ackerman
Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing.
Heart rhythm : the official journal of the Heart Rhythm Society 2005;2(10):1099-105.
2005: J J Koch; C J Porter; Michael J Ackerman
Acquired QT prolongation associated with esophagitis and acute weight loss: how to evaluate a prolonged QT interval.
Pediatric cardiology 2005;26(5):646-50.
2005: Sara L Van Driest; Oleksandr Gakh; Steve R Ommen; Grazia Isaya; Michael J Ackerman
Molecular and functional characterization of a human frataxin mutation found in hypertrophic cardiomyopathy.
Molecular genetics and metabolism 2005;85(4):280-5.
2005: Bi-Hua Tan; Carmen R Valdivia; Benjamin A Rok; Bin Ye; Karen M Ruwaldt; David J Tester; Michael J Ackerman; Jonathan C Makielski
Common human SCN5A polymorphisms have altered electrophysiology when expressed in Q1077 splice variants.
Heart rhythm : the official journal of the Heart Rhythm Society 2005;2(7):741-7.
2005: Brian P Delisle; Jessica K Slind; Jennifer A Kilby; Corey L Anderson; Blake D Anson; Ravi C Balijepalli; David J Tester; Michael J Ackerman; Timothy J Kamp; Craig T January
Intragenic suppression of trafficking-defective KCNH2 channels associated with long QT syndrome.
Molecular pharmacology 2005;68(1):233-40.
2005: Sara L Van Driest; Steve R Ommen; A Jamil Tajik; Bernard J Gersh; Michael J Ackerman
Yield of genetic testing in hypertrophic cardiomyopathy.
Mayo Clinic proceedings. Mayo Clinic 2005;80(6):739-44.
2005: David J Tester; Laura J Kopplin; Wendy Creighton; Allen P Burke; Michael J Ackerman
Pathogenesis of unexplained drowning: new insights from a molecular autopsy.
Mayo Clinic proceedings. Mayo Clinic 2005;80(5):596-600.
2005: David J Tester; Melissa L Will; Carla M Haglund; Michael J Ackerman
Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing.
Heart rhythm : the official journal of the Heart Rhythm Society 2005;2(5):507-17.
2005: Sara L Van Driest; Steve R Ommen; A Jamil Tajik; Bernard J Gersh; Michael J Ackerman
Sarcomeric genotyping in hypertrophic cardiomyopathy.
Mayo Clinic proceedings. Mayo Clinic 2005;80(4):463-9.
2005: Blake D Anson; Joel G R Weaver; Michael J Ackerman; Omobosola Akinsete; Keith Henry; Craig T January; andrew badley
Blockade of HERG channels by HIV protease inhibitors.
Lancet 2005;365(9460):682-6.
2005: Anant Khositseth; Joseph Hejlik; Win-Kuang Shen; Michael J Ackerman
Epinephrine-induced T-wave notching in congenital long QT syndrome.
Heart rhythm : the official journal of the Heart Rhythm Society 2005;2(2):141-6.
2004: Sara L Van Driest; Vlad C Vasile; Steve R Ommen; Melissa L Will; A Jamil Tajik; Bernard J Gersh; Michael J Ackerman
Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy.
Journal of the American College of Cardiology 2004;44(9):1903-10.
2004: Michael J Ackerman; Igor Splawski; Jonathan C Makielski; David J Tester; Melissa L Will; Katherine W Timothy; Mark T Keating; Gregg Jones; Monica Chadha; Christopher R Burrow; J Claiborne Stephens; Chuanbo Xu; Richard Judson; Mark E Curran
Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing.
Heart rhythm : the official journal of the Heart Rhythm Society 2004;1(5):600-7.
2004: David J Tester; Daniel B Spoon; Hector H Valdivia; Jonathan C Makielski; Michael J Ackerman
Targeted mutational analysis of the RyR2-encoded cardiac ryanodine receptor in sudden unexplained death: a molecular autopsy of 49 medical examiner/coroner's cases.
Mayo Clinic proceedings. Mayo Clinic 2004;79(11):1380-4.
2004: Grace Choi; Laura J Kopplin; David J Tester; Melissa L Will; Carla M Haglund; Michael J Ackerman
Spectrum and frequency of cardiac channel defects in swimming-triggered arrhythmia syndromes.
Circulation 2004;110(15):2119-24.
2004: Grace R Choi; Co-Burn J Porter; Michael J Ackerman
Sudden cardiac death and channelopathies: a review of implantable defibrillator therapy.
Pediatric clinics of North America 2004;51(5):1289-303.
2004: R Chatrath; C M Bell; Michael J Ackerman
Beta-blocker therapy failures in symptomatic probands with genotyped long-QT syndrome.
Pediatric cardiology 2004;25(5):459-65.
2004: Sara L Van Driest; Michele A Jaeger; Steve R Ommen; Melissa L Will; Bernard J Gersh; A Jamil Tajik; Michael J Ackerman
Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy.
Journal of the American College of Cardiology 2004;44(3):602-10.
2004: Michelle L Tipton; Michael J Ackerman
My child just fainted: no big deal or sudden-death warning?
Emergency medical services 2004;33(7):41-5.
2004: Dipika Sharma; Kathryn A Glatter; Valeriy Timofeyev; Dipika Tuteja; Zhao Zhang; Jennifer Rodriguez; David J Tester; Reginald I Low; Melvin M Scheinman; Michael J Ackerman; Nipavan Chiamvimonvat
Characterization of a KCNQ1/KVLQT1 polymorphism in Asian families with LQT2: implications for genetic testing.
Journal of molecular and cellular cardiology 2004;37(1):79-89.
2004: Blake D Anson; Michael J Ackerman; David J Tester; Melissa L Will; Brian P Delisle; Corey L Anderson; Craig T January
Molecular and functional characterization of common polymorphisms in HERG (KCNH2) potassium channels.
American journal of physiology. Heart and circulatory physiology 2004;286(6):H2434-41.
2004: Anant Khositseth; David J Tester; Melissa L Will; Carla M Bell; Michael J Ackerman
Identification of a common genetic substrate underlying postpartum cardiac events in congenital long QT syndrome.
Heart rhythm : the official journal of the Heart Rhythm Society 2004;1(1):60-4.
2004: Jan Nemec; Marie Buncová; Veronika Bůlková; Joseph Hejlik; Bruce Winter; Win-Kuang Shen; Michael J Ackerman
Heart rate dependence of the QT interval duration: differences among congenital long QT syndrome subtypes.
Journal of cardiovascular electrophysiology 2004;15(5):550-6.
2004: Carmen R Valdivia; David J Tester; Benjamin A Rok; Co-Burn J Porter; Thomas M Munger; Arshad Jahangir; Jonathan C Makielski; Michael J Ackerman
A trafficking defective, Brugada syndrome-causing SCN5A mutation rescued by drugs.
Cardiovascular research 2004;62(1):53-62.
2004: David J Tester; Jorge McCormack; Michael J Ackerman
Prenatal molecular genetic diagnosis of congenital long QT syndrome by strategic genotyping.
The American journal of cardiology 2004;93(6):788-91.
2003: Michael J Ackerman; David J Tester; Gregg S Jones; Melissa L Will; Christopher R Burrow; Mark E Curran
Ethnic differences in cardiac potassium channel variants: implications for genetic susceptibility to sudden cardiac death and genetic testing for congenital long QT syndrome.
Mayo Clinic proceedings. Mayo Clinic 2003;78(12):1479-87.
2003: Adriana Lee; Michael J Ackerman
Sudden unexplained death: evaluation of those left behind.
Lancet 2003;362(9394):1429-30.
2003: Jonathan C Makielski; Bin Ye; Carmen R Valdivia; Matthew D Pagel; Jielin Pu; David J Tester; Michael J Ackerman
A ubiquitous splice variant and a common polymorphism affect heterologous expression of recombinant human SCN5A heart sodium channels.
Circulation research 2003;93(9):821-8.
2003: Jason H Homme; Roger D White; Michael J Ackerman
Management of ventricular fibrillation or unstable ventricular tachycardia in patients with congenital long-QT syndrome: a suggested modification to ACLS guidelines.
Resuscitation 2003;59(1):111-5.
2003: Anant Khositseth; Matthew W Martinez; David J Driscoll; Michael J Ackerman
Syncope in children and adolescents and the congenital long QT syndrome.
The American journal of cardiology 2003;92(6):746-9.
2003: Jan Nemec; Michael J Ackerman; David J Tester; Joseph Hejlik; Win-Kuang Shen
Catecholamine-provoked microvoltage T wave alternans in genotyped long QT syndrome.
Pacing and clinical electrophysiology : PACE 2003;26(8):1660-7.
2003: Sara L Van Driest; Erik G Ellsworth; Steve R Ommen; A Jamil Tajik; Bernard J Gersh; Michael J Ackerman
Prevalence and spectrum of thin filament mutations in an outpatient referral population with hypertrophic cardiomyopathy.
Circulation 2003;108(4):445-51.
2003: Anant Khositseth; Jan Nemec; Joseph Hejlik; Win-Kuang Shen; Michael J Ackerman
Effect of phenylephrine provocation on dispersion of repolarization in congenital long QT syndrome.
Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2003;8(3):208-14.
2003: Bin Ye; Carmen R Valdivia; Michael J Ackerman; Jonathan C Makielski
A common human SCN5A polymorphism modifies expression of an arrhythmia causing mutation.
Physiological genomics 2003;12(3):187-93.
2003: Jan Nemec; Joseph Hejlik; Win-Kuang Shen; Michael J Ackerman
Catecholamine-induced T-wave lability in congenital long QT syndrome: a novel phenomenon associated with syncope and cardiac arrest.
Mayo Clinic proceedings. Mayo Clinic 2003;78(1):40-50.
2002: Sara L Van Driest; Michael J Ackerman; Steve R Ommen; Rameen Shakur; Melissa L Will; Rick A Nishimura; A Jamil Tajik; Bernard J Gersh
Prevalence and severity of "benign" mutations in the beta-myosin heavy chain, cardiac troponin T, and alpha-tropomyosin genes in hypertrophic cardiomyopathy.
Circulation 2002;106(24):3085-90.
2002: Sara L Van Driest; Melissa L Will; Dianne L Atkins; Michael J Ackerman
A novel TPM1 mutation in a family with hypertrophic cardiomyopathy and sudden cardiac death in childhood.
The American journal of cardiology 2002;90(10):1123-7.
2002: Carmen R Valdivia; Michael J Ackerman; David J Tester; Tomoyuki Wada; Jorge McCormack; Bin Ye; Jonathan C Makielski
A novel SCN5A arrhythmia mutation, M1766L, with expression defect rescued by mexiletine.
Cardiovascular research 2002;55(2):279-89.
2002: Michael J Ackerman; Sara L VanDriest; Steve R Ommen; Melissa L Will; Rick A Nishimura; A Jamil Tajik; Bernard J Gersh
Prevalence and age-dependence of malignant mutations in the beta-myosin heavy chain and troponin T genes in hypertrophic cardiomyopathy: a comprehensive outpatient perspective.
Journal of the American College of Cardiology 2002;39(12):2042-8.
2002: Michael J Ackerman; Anant Khositseth; David J Tester; Joseph Hejlik; Win-Kuang Shen; Co-Burn J Porter
Epinephrine-induced QT interval prolongation: a gene-specific paradoxical response in congenital long QT syndrome.
Mayo Clinic proceedings. Mayo Clinic 2002;77(5):413-21.
2002: Ritu Chatrath; Co-Burn J Porter; Michael J Ackerman
Role of transvenous implantable cardioverter-defibrillators in preventing sudden cardiac death in children, adolescents, and young adults.
Mayo Clinic proceedings. Mayo Clinic 2002;77(3):226-31.
2001: Michael J Ackerman; B L Siu; W Q Sturner; David J Tester; Carmen R Valdivia; Jonathan C Makielski; J A Towbin
Postmortem molecular analysis of SCN5A defects in sudden infant death syndrome.
JAMA : the journal of the American Medical Association 2001;286(18):2264-9.
1999: Michael J Ackerman; David J Tester; C J Porter
Swimming, a gene-specific arrhythmogenic trigger for inherited long QT syndrome.
Mayo Clinic proceedings. Mayo Clinic 1999;74(11):1088-94.
1999: Michael J Ackerman; David J Tester; C J Porter; W D Edwards
Molecular diagnosis of the inherited long-QT syndrome in a woman who died after near-drowning.
The New England journal of medicine 1999;341(15):1121-5.
1998: Michael J Ackerman
The long QT syndrome: ion channel diseases of the heart.
Mayo Clinic proceedings. Mayo Clinic 1998;73(3):250-69.